|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kiora Pharmaceuticals (KPRX) |
|
|
$0.19 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
12,653,000 |
| Market
Cap: |
2.37(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.187 - $0.187 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kiora Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Romano Sarah |
Chief Financial Officer |
• – – |
2020-10-02 |
4 |
D |
$3.88 |
$380 |
D/D |
(98) |
25,916 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2020-09-02 |
4 |
D |
$3.94 |
$382 |
D/D |
(97) |
26,014 |
|
- |
|
| Manzo Michael P. |
VP of Engineering |
• – – |
2020-09-02 |
4 |
D |
$3.94 |
$382 |
D/D |
(97) |
17,693 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2020-09-02 |
4 |
D |
$3.94 |
$382 |
D/D |
(97) |
17,656 |
|
- |
|
| From Stephen |
President and CEO |
• • – |
2020-09-02 |
4 |
D |
$3.94 |
$2,474 |
D/D |
(628) |
79,835 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2020-08-04 |
4 |
D |
$4.11 |
$390 |
D/D |
(95) |
26,111 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2020-08-04 |
4 |
D |
$4.11 |
$378 |
D/D |
(92) |
17,753 |
|
- |
|
| From Stephen |
President and CEO |
• • – |
2020-08-04 |
4 |
D |
$4.11 |
$2,528 |
D/D |
(615) |
80,463 |
|
- |
|
| Manzo Michael P. |
VP of Engineering |
• – – |
2020-08-04 |
4 |
D |
$4.11 |
$390 |
D/D |
(95) |
17,790 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2020-07-02 |
4 |
D |
$4.82 |
$468 |
D/D |
(97) |
26,206 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2020-07-02 |
4 |
D |
$4.82 |
$453 |
D/D |
(94) |
17,845 |
|
- |
|
| From Stephen |
President and CEO |
• • • |
2020-07-02 |
4 |
D |
$4.82 |
$3,013 |
D/D |
(625) |
81,078 |
|
- |
|
| Manzo Michael P. |
VP of Engineering |
• – – |
2020-07-02 |
4 |
D |
$4.82 |
$468 |
D/D |
(97) |
17,885 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2020-06-03 |
4 |
D |
$5.11 |
$480 |
D/D |
(94) |
17,939 |
|
- |
|
| From Stephen |
President and CEO |
• • – |
2020-06-03 |
4 |
D |
$5.11 |
$3,204 |
D/D |
(627) |
81,703 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2020-06-03 |
4 |
D |
$5.11 |
$480 |
D/D |
(94) |
26,303 |
|
- |
|
| Manzo Michael P. |
VP of Engineering |
• – – |
2020-06-03 |
4 |
D |
$5.11 |
$480 |
D/D |
(94) |
17,982 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2020-05-05 |
4 |
D |
$5.10 |
$474 |
D/D |
(93) |
26,397 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2020-05-05 |
4 |
D |
$5.10 |
$576 |
D/D |
(113) |
18,033 |
|
- |
|
| From Stephen |
President and CEO |
• • – |
2020-05-05 |
4 |
D |
$5.10 |
$3,147 |
D/D |
(617) |
82,330 |
|
- |
|
| Manzo Michael P. |
VP of Engineering |
• – – |
2020-05-05 |
4 |
D |
$5.10 |
$474 |
D/D |
(93) |
18,076 |
|
- |
|
| From Stephen |
President and CEO |
• • – |
2020-04-02 |
4 |
D |
$4.97 |
$3,330 |
D/D |
(670) |
82,947 |
|
- |
|
| Mann Brenda |
VP of Research & Development |
• – – |
2020-04-02 |
4 |
D |
$4.97 |
$606 |
D/D |
(122) |
18,146 |
|
- |
|
| Manzo Michael P. |
VP of Engineering |
• – – |
2020-04-02 |
4 |
D |
$4.97 |
$606 |
D/D |
(122) |
18,169 |
|
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2020-04-02 |
4 |
D |
$4.97 |
$606 |
D/D |
(122) |
26,490 |
|
- |
|
289 Records found
|
|
Page 4 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
